Aytu BioPharma, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2022 | $-28.8M | $-28.8M | $0 | $5.2M |
| FY2023 | $-5.1M | $-5.1M | — | $6.0M |
| FY2024 | $-1.4M | $-1.7M | $329.0K | $2.4M |
| FY2025 | $-1.9M | $-2.2M | $228.0K | $576.0K |
| FY2026 | $3.3M | $3.3M | $29.0K | $691.0K |